Dark Streaming/Mobile Old Site Home Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
06:37:13 EST Sun 08 Feb 2026
Enter Symbol
or Name
USA
CA



Q:NEO - NEOGENOMICS INC - https://www.neogenomics.com
Sym-XBid - AskLastChg%ChVol$Vol#TrOpen-Hi-LoYear Hi-LoLast TrNewsDelay
NEO - Q0.211.11·11.850.211.42+0.151.32,406.326,53816,08911.43  11.58  11.1614.72  4.7216:20:00Jan 2715 min RT 2¢

Recent Trades - Last 10 of 16089
Time ETExPriceChangeVolume
16:20:00Q11.420.15498
16:10:04Q11.420.151
16:10:04Q11.420.151
16:10:04Q11.420.151
16:10:04Q11.420.151
16:08:13Q11.420.156,442
16:04:21Q11.420.151
16:04:20Q11.420.151
16:04:20Q11.420.151
16:04:17Q11.420.151

Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS

Recent Bulletins
Date ETSymbolTypeHeadline
2026-01-27 07:05U:NEONews ReleaseNeoGenomics to Report Fourth Quarter and Full Year 2025 Financial Results on February 17, 2026
2026-01-12 07:05U:NEONews ReleaseNeoGenomics Announces Preliminary Fourth Quarter and Full-Year 2025 Revenue
2026-01-05 07:05U:NEONews ReleaseNeoGenomics to Participate in the 44th Annual J.P. Morgan Healthcare Conference
2025-12-30 07:05U:NEONews ReleaseNeoGenomics Appoints Diagnostics and Lab Services Industry Veteran John P. "Jack" Kenny to its Board of Directors
2025-12-15 07:05U:NEONews ReleaseNeoGenomics Announces that Natera Has Voluntarily Withdrawn its Appeal in Ongoing RaDaR Patent Litigation
2025-12-10 07:05U:NEONews ReleaseNeoGenomics to Present New ctDNA Research at SABCS 2025
2025-12-08 08:05U:NEONews ReleaseNeoGenomics to Present Real-World Study on Comprehensive Genomic Profiling in Myeloid Malignancies at ASH 2025
2025-11-06 07:05U:NEONews ReleaseNeoGenomics to Participate in Upcoming Investor Conferences
2025-10-30 12:51U:NEONews ReleaseNeoGenomics to Present RaDaR ST Bridging Study at ISLB 2025, Demonstrating Reliable MRD Detection Across Solid Tumors
2025-10-28 07:05U:NEONews ReleaseNeoGenomics Reports Third Quarter 2025 Results
2025-10-14 07:05U:NEONews ReleaseNeoGenomics to Highlight RaDaR ST MRD Assay at ESMO Congress 2025
2025-10-07 07:05U:NEONews ReleaseNeoGenomics to Report Third Quarter 2025 Financial Results on October 28, 2025
2025-08-29 07:05U:NEONews ReleaseCourt Rules for NeoGenomics in Patent Infringement Lawsuit Against Natera
2025-07-30 07:05U:NEONews ReleaseNeoGenomics Launches PanTracer LBx, Expanding Access to Comprehensive Genomic Profiling with Liquid Biopsy
2025-07-29 07:05U:NEONews ReleaseNeoGenomics Reports Second Quarter 2025 Results
2025-07-01 07:05U:NEONews ReleaseNeoGenomics to Report Second Quarter 2025 Financial Results on July 29, 2025
2025-06-30 07:05U:NEONews ReleaseNeoGenomics Announces PanTracer Tissue and PanTracer Tissue + HRD Now Available to Support More Informed and Timely Cancer Care
2025-06-24 07:05U:NEONews ReleaseNeoGenomics Appoints Dr. Marjorie Green to Board of Directors
2025-05-28 07:10U:NEONews ReleaseNeoGenomics Debuts PanTracer Family of Genomic Profiling Tests at ASCO 2025
2025-05-22 07:10U:NEONews ReleaseNeoGenomics Launches c-MET CDx Assay to Guide Treatment Decisions for Advanced Non-Small Cell Lung Cancer